结核临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 结核（国际通用名 tuberculosis）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖肺结核、TB等说法。

正在招募的结核新药试验

• Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students

  不适用招募中意大利NCT05756582

• Shorter and Safer Treatment Regimens for Latent TB

  II 期 / III 期招募中BeninBrazil加拿大IndonesiaNCT06498414

• Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis

  不适用招募中意大利NCT06764576

• Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB

  II 期招募中MozambiquePhilippinesRussiaSouth AfricaNCT02354014

• A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide

  II 期招募中South AfricaNCT06748937

• Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

  II 期招募中BrazilIndiaKenyaMalawiNCT05383742

• Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

  III 期招募中中国NCT05081401

• Gene Expression Profiles in Spinal Tuberculosis.

  不适用招募中South AfricaNCT05610098

• B-PaLMZ for TB Meningitis

  II 期招募中UgandaNCT07227779

• A PAN-USR TB Multi-Center Trial

  III 期招募中中国NCT06905522

• Digital Health Intervention to Improve TPT Uptake

  不适用招募中EthiopiaNCT07313995

• Rehabilitation of People With Post-tuberculosis Lung Disease

  不适用招募中BrazilNCT06127641